Nyingi Kemmer

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao et al. · Gastroenterology · 2019 · 326 citations · Full text

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali et al. · Journal of Hepatology · 2019 · 152 citations · Full text

Severe Portal Hypertension, Hepatology, Liver Physiology +8

Alpha-1-Antitrypsin Deficiency: Outcomes After Liver Transplantation

Nyingi Kemmer, Tiffany E. Kaiser, V. Zacharias et al. · Transplantation Proceedings · 2008 · 84 citations

Transplantation, Autoimmune Disease, Hepatology +8

Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma

Abhishek Mathur, Edson Franco, John P. Leone et al. · HPB · 2012 · 76 citations · Full text

Obesity, Obesity Portends, Earlier Recurrence +9

Nonalcoholic Fatty Liver Disease Epidemic and Its Implications for Liver Transplantation

Nyingi Kemmer, Guy Neff, Edson Franco et al. · Transplantation · 2013 · 68 citations

Solid Organ Transplantation, Pathology, Fatty Liver Disease +19